SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026119
Filing Date
2021-05-10
Accepted
2021-05-10 17:02:11
Documents
54
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-10q_20210331.htm   iXBRL 10-Q 1902246
2 EX-31.1 axsm-ex311_9.htm EX-31.1 11386
3 EX-31.2 axsm-ex312_8.htm EX-31.2 11371
4 EX-32.1 axsm-ex321_7.htm EX-32.1 5259
5 EX-32.2 axsm-ex322_6.htm EX-32.2 5167
  Complete submission text file 0001564590-21-026119.txt   5900684

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA axsm-20210331.xsd EX-101.SCH 45094
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE axsm-20210331_cal.xml EX-101.CAL 36254
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE axsm-20210331_def.xml EX-101.DEF 116164
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE axsm-20210331_lab.xml EX-101.LAB 377053
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE axsm-20210331_pre.xml EX-101.PRE 255743
11 EXTRACTED XBRL INSTANCE DOCUMENT axsm-10q_20210331_htm.xml XML 802724
Mailing Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007
Business Address 22 CORTLANDT STREET, 16TH FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 21908197
SIC: 2834 Pharmaceutical Preparations